Výsledky vyhledávání

Nalezeno záznamů: 24  
Váš dotaz: Autor = ("hrustincova")
  1. 1.
    HRUSTINCOVA, A.; TRSOVA, I.; KREJCIK, Z.; KUNDRAT, D.; BELICKOVA, M.; KAISRLIKOVA, M.; VESELA, J.; KLEMA, J.; RYSAVY, P.; SUTTNAR, J.; HLAVACKOVA, A.; JONASOVA, A.; CERMAK, J.; DOSTALOVA MERKEROVA, M. SF3B1 mutations and their impact on cellular bioenergetics in myelodysplastic syndromes. Leukemia research. 2023, vol. 128, no. Supplement, s. 71. ISSN 0145-2126.
  2. 2.
    TRSOVA, I.; HRUSTINCOVA, A.; KREJCIK, Z.; KUNDRAT, D.; HOLOUBEK, A.; STAFLOVA, K.; JANSTOVA, L.; VANIKOVA, S.; SZIKSZAI, K.; KLEMA, J.; RYSAVY, P.; BELICKOVA, M.; KAISRLIKOVA, M.; VESELA, J.; CERMAK, J.; JONASOVA, A.; DOSTAL, J.; FRIC, J.; MUSIL, J.; DOSTALOVA MERKEROVA, M.G Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1. Molecular oncology. 2023, vol. 17, no. 12, s. 2565-2583. ISSN 1574-7891.
  3. 3.
    DOSTALOVA MERKEROVA, M.G; KLEMA, J.; KUNDRAT, D.; SZIKSZAI, K.; KREJCIK, Z.; HRUSTINCOVA, A.; TRSOVA, I.; LE, A.V.; CERMAK, J.; JONASOVA, A.; BELICKOVA, M. Noncoding RNAs and their response predictive value in azacitidine-treated patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes. Cancer genomics and proteomics. 2022, vol. 19, no. 2, s. 205-228. ISSN 1109-6535.
  4. 4.
    DOSTALOVA MERKEROVA, M.; KUNDRAT, D.; KREJCIK, Z.; HRUSTINCOVA, A.; TRSOVA, I.; SZIKSZAI, K.; KAISRLIKOVA, M.; VESELA, J.; KLEMA, J.; CERMAK, J.; BELICKOVA, M. Circular RNAs in myelodysplastic syndromes and impact of SF3B1 mutations on their expression.
  5. 5.
    DOSTALOVA MERKEROVA, M.; SZIKSZAI, K.; KREJCIK, Z.; KLEMA, J.; HRUSTINCOVA, A.; KUNDRAT, D.; PECHERKOVA, P.; CERMAK, J.; JONASOVA, A.; BELICKOVA, M. LncRNA profiling reveals that the deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 is associated with higher-risk myelodysplastic syndrome. [Prezentováno: 21. pražské hematologické dny: hematologie 2021: post-ASH. Praha, 28.1.-29.1.2021.].
  6. 6.
    MERKEROVA, M.; KLEMA, J.; KUNDRAT, D.; KREJCIK, Z.; HRUSTINCOVA, A.; TRSOVA, I.; CERMAK, J.; JONASOVA, A.; BELICKOVA, M. Noncoding RNAs in MDS pathogenesis and their predictive value in azacitidine response. Leukemia research. 2021, vol. 108, no. S, art. no. 106681.25. ISSN 0145-2126.
  7. 7.
    HRUSTINCOVA, A.; KREJCIK, Z.; KUNDRAT, D.; SZIKSZAI, K.; BELICKOVA, M.; PECHERKOVA, P.; KLEMA, J.; VESELA, J.; HRUBA, M.; CERMAK, J.; HRDINOVA, T.; KRIJT, M.; VALKA, J.; JONASOVA, A.; MERKEROVA, M.D.G Circulating small noncoding RNAs have specific expression patterns in plasma and extracellular vesicles in myelodysplastic syndromes and are predictive of patient outcome. Cells. 2020, vol. 9, no. 4, art. no. E794. ISSN 2073-4409.
  8. 8.
    SZIKSZAI, K.; KREJCIK, Z.; KLEMA, J.; LOUDOVA, N.; HRUSTINCOVA, A.; BELICKOVA, M.; HRUBA, M.; VESELA, J.; STRANECKY, V.; KUNDRAT, D.; PECHERKOVA, P.; CERMAK, J.; JONASOVA, A.; DOSTALOVA MERKEROVA, M.G LncRNA profiling reveals that the deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 is associated with higher-risk myelodysplastic syndrome. Cancers. 2020, vol. 12, no. 10, art. no. 2726. ISSN 2072-6694.
  9. 9.
    HRUŠTINCOVÁ, A.; SZIKSZAI, K.; KREJČÍK, Z.; LOUDOVÁ, N.; DOSTÁLOVÁ MERKEROVÁ, M. Noncoding RNAs in myelodysplastic syndromes. In: FUCHS, O. (ed.) Recent developments in myelodysplastic syndromes [online]. London: IntechOpen, 2019, s. 85-99. ISBN 978-1-78985-478-7. Dostupný z WWW: <https://doi.org/10.5772/intechopen.79767>.
  10. 10.
    DOSTALOVA MERKEROVA, M.; HRUSTINCOVA, A.; KREJCIK, Z.; KUNDRAT, D.; SZIKSZAI, K.; CERMAK, J.; VESELA, J.; HRUBA, M.; BELICKOVA, M. Circulating small noncoding RNAs as novel semi-invasive markers of patient survival in myelodysplastic syndromes. Blood. 2019, vol. 134, no. S1, s. 3004. ISSN 0006-4971.

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.

Přijmout všeNastaveníOdmítnout vše